Correlation Between Unity Biotechnology and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Lyra Therapeutics, you can compare the effects of market volatilities on Unity Biotechnology and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Lyra Therapeutics.
Diversification Opportunities for Unity Biotechnology and Lyra Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Unity and Lyra is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Lyra Therapeutics
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Lyra Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Unity Biotechnology is 2.3 times less risky than Lyra Therapeutics. The stock trades about -0.19 of its potential returns per unit of risk. The Lyra Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 24.00 in Lyra Therapeutics on September 26, 2024 and sell it today you would lose (7.00) from holding Lyra Therapeutics or give up 29.17% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Lyra Therapeutics
Performance |
| Timeline |
| Unity Biotechnology |
| Lyra Therapeutics |
Unity Biotechnology and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Lyra Therapeutics
The main advantage of trading using opposite Unity Biotechnology and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
| Lyra Therapeutics vs. Fate Therapeutics | Lyra Therapeutics vs. Caribou Biosciences | Lyra Therapeutics vs. Karyopharm Therapeutics | Lyra Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |